Why is Rohto Pharmaceutical Co., Ltd. ?
1
Flat results in Jun 26
- ROCE(HY) Lowest at 11.5%
2
With ROE of 12.72%, it has a attractive valuation with a 1.90 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 15.94%, its profits have risen by 21.6% ; the PEG ratio of the company is 0.7
- At the current price, the company has a high dividend yield of 0
3
Underperformed the market in the last 1 year
- The stock has generated a return of 15.94% in the last 1 year, much lower than market (Japan Nikkei 225) returns of 59.79%
How much should you hold?
- Overall Portfolio exposure to Rohto Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to FMCG should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in FMCG)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Rohto Pharmaceutical Co., Ltd. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Rohto Pharmaceutical Co., Ltd.
15.94%
-0.11
33.30%
Japan Nikkei 225
60.14%
2.04
29.37%
Quality key factors
Factor
Value
Sales Growth (5y)
13.28%
EBIT Growth (5y)
12.88%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.09
Sales to Capital Employed (avg)
0.99
Tax Ratio
26.49%
Dividend Payout Ratio
30.35%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
20.11%
ROE (avg)
12.73%
Valuation Key Factors 
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
1.90
EV to EBIT
13.14
EV to EBITDA
9.15
EV to Capital Employed
1.97
EV to Sales
1.56
PEG Ratio
0.69
Dividend Yield
NA
ROCE (Latest)
15.00%
ROE (Latest)
12.72%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Bullish
Technical Movement
6What is working for the Company
NET SALES(Q)
Highest at JPY 91,624 MM
RAW MATERIAL COST(Y)
Fallen by -0.72% (YoY
CASH AND EQV(HY)
Highest at JPY 171,587 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 2.4 times
DEBTORS TURNOVER RATIO(HY)
Highest at 5.14 times
-2What is not working for the Company
ROCE(HY)
Lowest at 11.5%
Here's what is working for Rohto Pharmaceutical Co., Ltd.
Net Sales
Highest at JPY 91,624 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (JPY MM)
Cash and Eqv
Highest at JPY 171,587 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Inventory Turnover Ratio
Highest at 2.4 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 5.14 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -0.72% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales






